drugset / Trial / NCT00638456

Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis

NCT00638456

Phase 2 Completed 32 enrolled Ranjan Dohil Meritage Pharma, Inc. · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is designed to evaluate whether or not oral viscous budesonide is effective in treating children with Eosinophilic Esophagitis.

Timeline

Start
2008-02
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Budesonide Small molecule 1 mg Oral
Comparator Budesonide Small molecule 2 mg Oral
Comparator Lansoprazole Other / unclassified